Summary
patients treated
Has anyone ever benefited from stem cell?
For the first time, umbilical cord blood cells were successfully used in 1988 in France. Several years later, in 2007, this method was also introduced by FamiCord Group in Poland. So far, umbilical cord blood stem cells have been transplanted over 40,000 times worldwide, saving peoples’ lives and health.
FamiCord Group enables their clients innovative treatment with stem cells. Check the full list of patients, suffered from diverse disorders, who benefited from it.
List of patients
| No. | Source | Source type | Diagnosis | Medical sector | Year of application | Therapy | Country | Age of the recipient |
|---|---|---|---|---|---|---|---|---|
| 1901 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 1902 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 1903 | Bone Marrow | Allogeneic | Chronic Granulomatous Disease | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 1904 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 44 |
| 1905 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 1906 | Bone Marrow | Allogeneic | Chronic Myelogenous Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 1907 | Bone Marrow | Allogeneic | Chronic Myelomonocytic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 1908 | Bone Marrow | Allogeneic | Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 1909 | Bone Marrow | Allogeneic | Combined Immunodeficiency Syndrome With Hyper-Igm | Hematology | 2021 | Standard Therapy | Poland | 5 |
| 1910 | Bone Marrow | Allogeneic | Fanconi Anemia | Hematology | 2021 | Standard Therapy | Poland | 4 |
| 1911 | Bone Marrow | Allogeneic | Hemophagocytic Lymphohistiocytosis (Hlh) | Hematology | 2021 | Standard Therapy | Poland | 3 |
| 1912 | Bone Marrow | Allogeneic | Hurler Syndrome | Hematology | 2021 | Standard Therapy | Poland | 3 |
| 1913 | Bone Marrow | Allogeneic | Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 1914 | Bone Marrow | Allogeneic | Inherited Immune System Disorder | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 1915 | Bone Marrow | Allogeneic | Ipex- Other Immune | Hematology | 2021 | Standard Therapy | Poland | 20 |
| 1916 | Bone Marrow | Allogeneic | Leukemia Lymphoblastic Acuta | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 1917 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 1918 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 10 |
| 1919 | Bone Marrow | Allogeneic | Myelodysplastic Syndrome | Hematology | 2021 | Standard Therapy | Poland | 2 |
| 1920 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 30 |
| 1921 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 67 |
| 1922 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 1923 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 1924 | Bone Marrow | Allogeneic | No Data | Hematology | 2021 | Standard Therapy | Poland | 69 |
| 1925 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 1926 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 14 |
| 1927 | Bone Marrow | Allogeneic | Non-Hodgkin Lymphoma | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 1928 | Bone Marrow | Allogeneic | Osteopetrosis | Hematology | 2021 | Standard Therapy | Poland | 7 |
| 1929 | Bone Marrow | Allogeneic | Other Leukemia Specify | Hematology | 2021 | Standard Therapy | Poland | 35 |
| 1930 | Bone Marrow | Allogeneic | Other Myelofibrosis | Hematology | 2021 | Standard Therapy | Poland | 72 |
| 1931 | Bone Marrow | Allogeneic | Refractory Cytopenia | Hematology | 2021 | Standard Therapy | Poland | 7 |
| 1932 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 23 |
| 1933 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 53 |
| 1934 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 12 |
| 1935 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 5 |
| 1936 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 13 |
| 1937 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 12 |
| 1938 | Bone Marrow | Allogeneic | Severe Aplastic Anemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 1939 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 1940 | Bone Marrow | Allogeneic | Severe Combined Immunodeficiency | Hematology | 2021 | Standard Therapy | Poland | 1 |
| 1941 | Bone Marrow | Allogeneic | Wiskott-Aldrich Syndrome | Hematology | 2021 | Standard Therapy | Poland | 9 months |
| 1942 | Apheresis | Allogeneic | Acute Biphenotypic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 28 |
| 1943 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 17 |
| 1944 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
| 1945 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
| 1946 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 31 |
| 1947 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 24 |
| 1948 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 27 |
| 1949 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 54 |
| 1950 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 51 |
| 1951 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 65 |
| 1952 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 1953 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 10 |
| 1954 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 23 |
| 1955 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 5 |
| 1956 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 28 |
| 1957 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 1958 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 13 |
| 1959 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 1960 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
| 1961 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 20 |
| 1962 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 1963 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 52 |
| 1964 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 1965 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 32 |
| 1966 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 19 |
| 1967 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 1968 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 42 |
| 1969 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 3 |
| 1970 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 29 |
| 1971 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 8 |
| 1972 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 54 |
| 1973 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 20 |
| 1974 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 6 |
| 1975 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 61 |
| 1976 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 24 |
| 1977 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 1978 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia | Hematology | 2021 | Standard Therapy | Poland | 38 |
| 1979 | Apheresis | Allogeneic | Acute Lymphoblastic Leukemia – Relapse | Hematology | 2021 | Standard Therapy | Poland | 38 |
| 1980 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 40 |
| 1981 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 58 |
| 1982 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 23 |
| 1983 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 59 |
| 1984 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 62 |
| 1985 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 73 |
| 1986 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 41 |
| 1987 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 48 |
| 1988 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 64 |
| 1989 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 24 |
| 1990 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 50 |
| 1991 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 55 |
| 1992 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 66 |
| 1993 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 46 |
| 1994 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 69 |
| 1995 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 47 |
| 1996 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 45 |
| 1997 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 1998 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 68 |
| 1999 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 70 |
| 2000 | Apheresis | Allogeneic | Acute Myeloid Leukemia | Hematology | 2021 | Standard Therapy | Poland | 63 |